- Home
- RPID vs NMRA Comparison
RPID vs NMRA Comparison
Compare RPID & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPID
- NMRA
- Stock Information
- Founded
- RPID 2006
- NMRA 2019
- Country
- RPID United States
- NMRA United States
- Employees
- RPID N/A
- NMRA N/A
- Industry
- RPID Medical Specialities
- NMRA
- Sector
- RPID Health Care
- NMRA
- Exchange
- RPID Nasdaq
- NMRA Nasdaq
- Market Cap
- RPID 138.9M
- NMRA 121.0M
- IPO Year
- RPID 2021
- NMRA 2023
- Fundamental
- Price
- RPID $3.47
- NMRA $1.06
- Analyst Decision
- RPID Buy
- NMRA Buy
- Analyst Count
- RPID 1
- NMRA 8
- Target Price
- RPID $8.00
- NMRA $9.29
- AVG Volume (30 Days)
- RPID 80.0K
- NMRA 1.4M
- Earning Date
- RPID 08-01-2025
- NMRA 08-05-2025
- Dividend Yield
- RPID N/A
- NMRA N/A
- EPS Growth
- RPID N/A
- NMRA N/A
- EPS
- RPID N/A
- NMRA N/A
- Revenue
- RPID $29,645,000.00
- NMRA N/A
- Revenue This Year
- RPID $18.54
- NMRA N/A
- Revenue Next Year
- RPID $20.55
- NMRA N/A
- P/E Ratio
- RPID N/A
- NMRA N/A
- Revenue Growth
- RPID 28.36
- NMRA N/A
- 52 Week Low
- RPID $0.61
- NMRA $0.61
- 52 Week High
- RPID $4.04
- NMRA $17.19
- Technical
- Relative Strength Index (RSI)
- RPID 52.30
- NMRA 67.61
- Support Level
- RPID $3.45
- NMRA $0.72
- Resistance Level
- RPID $3.77
- NMRA $0.85
- Average True Range (ATR)
- RPID 0.23
- NMRA 0.08
- MACD
- RPID -0.02
- NMRA 0.02
- Stochastic Oscillator
- RPID 61.04
- NMRA 100.00
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.